Liang et al. synthesized a series of indole-piperazine derivatives as selective histone deacetylase 6 (HDAC6) inhibitors, aiming to treat neurodegenerative diseases like Alzheimer’s disease [183]. The gene discussed is HDAC6; the disease is early-onset autosomal dominant Alzheimer disease.